Patents by Inventor Jurgen T. ROHR

Jurgen T. ROHR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Semi-synthetic mithramycin derivatives with anti-cancer activity
    Patent number: 9447135
    Abstract: Mithramycin derivatives and their pharmaceutically acceptable salts are disclosed. The mithramycin derivatives can be used in the treatment of Ewing sarcoma or other cancer or neuro-disease associated with an aberrant erythroblast transformation-specific transcription factor.
    Type: Grant
    Filed: May 20, 2015
    Date of Patent: September 20, 2016
    Assignee: UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
    Inventors: Jurgen T. Rohr, Daniel Scott, Markos Leggas, Jhong-Min Chen, Oleg V. Tsodikov
  • SEMI-SYNTHETIC MITHRAMYCIN DERIVATIVES WITH ANTI-CANCER ACTIVITY
    Publication number: 20160024130
    Abstract: Mithramycin derivatives and their pharmaceutically acceptable salts are disclosed. The mithramycin derivatives can be used in the treatment of Ewing sarcoma or other cancer or neuro-disease associated with an aberrant erythroblast transformation-specific transcription factor.
    Type: Application
    Filed: May 20, 2015
    Publication date: January 28, 2016
    Inventors: Jurgen T. ROHR, Daniel SCOTT, Markos LEGGAS, Jhong-Min CHEN, Oleg V. TSODIKOV